Finally, this may be multifactorial secondary to above normal IGF-2 production, reduced hepatic glycogen stores, and gluconeogenesis in the setting of metastases and poor nutrition, and excessive consumption from significant abdominopelvic tumor metabolic burden. This evidence concerns the gene IGF2 and neoplasm.